This content is machine translated Management of dyslipidemia Lipid-lowering agents for secondary prophylaxis also effective in elderly patients A recent meta-analysis published in the Lancet concluded that lipid lowering achieved comparable reductions in cardiovascular events in people over 75 years of age as in younger individuals. In elderly…
View Post 2 min This content is machine translated Hyperkalemia Hyperkalemia from a nephrological and cardiological point of view. Patients with cardiac and/or renal insufficiency often experience electrolyte imbalance, which in many cases is life-threatening. Hyperkalemia can be caused by the underlying disease itself, but also by its treatment…
View Post 3 min This content is machine translated Lipid Management Secondary prevention effective and safe even in elderly patients Elderly patients >75 years of age with existing atherosclerotic cardiovascular disease should be subjected to effective lipid lowering after considering their health status and with the help of regular follow-up.…
View Post 2 min This content is machine translated Diabetes Management Fresh wind through new possibilities – what is now possible In addition to the metabolic syndrome, type 2 diabetes also affects the blood vessels, heart and kidneys, among other things – this has been revealed by scientific research into the…
View Post 3 min This content is machine translated Direct oral anticoagulants DOAKs in renal insufficiency – GFR tipping the scales Any anticoagulation is a balancing act between thromboembolism and bleeding risk. This is particularly true in the case of chronic kidney dysfunction (CKD). In mild to moderate renal disease, all…
View Post 12 min This content is machine translated Heart failure Physical training in patients with HFrEF and HFpEF. The increasing prevalence of heart failure is a major medical and economic problem. The number of patients hospitalized for heart failure has been increasing for years. The clinical picture of… CME-Test
View Post 3 min This content is machine translated Heart failure The “Fantastic Four” for optimal HFrEF therapy The conclusion of a recent article in the European Heart Journal is that ARNI and SGLT-2 inhibitors should be combined in HFrEF patients. Treatment is most promising when supplemented with…
View Post 7 min This content is machine translated Supraventricular tachycardias ECG interpretation in SVT Supraventricular tachycardia (SVT) occurs in the general population with a prevalence of approximately 2-3/1000 population. Many people can be helped by adequate diagnosis and treatment of arrhythmias, and the correct… CME-Test
View Post 4 min This content is machine translated Blood pressure reduction How low for over 80s and frailty? In antihypertensive therapy in the 80-plus age group, it is important to weigh risk and benefit individually and not to treat strictly according to target values. Frailty (“frailness”) is an…
View Post 2 min This content is machine translated Telemedicine Computer model creates heart twin and supports therapy management Technical support is becoming increasingly important in diagnostics and therapy. Opportunities are also advancing in cardiology. Mathematical image processing can now be used to create a digital twin of the…
View Post 2 min This content is machine translated Glucagon-like peptide 1 (GLP1) analogues The future of diabetes management has begun Diabetes does not hurt – one would almost like to add “unfortunately”. This is because the number of unreported cases of affected patients is still high. Possible late effects of…
